Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022094603> ?p ?o ?g. }
- W2022094603 endingPage "1237" @default.
- W2022094603 startingPage "1222" @default.
- W2022094603 abstract "A novel α7 nAChR agonist, 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (24, CP-810,123), has been identified as a potential treatment for cognitive deficits associated with psychiatric or neurological conditions including schizophrenia and Alzheimer’s disease. Compound 24 is a potent and selective compound with excellent pharmaceutical properties. In rodent, the compound displays high oral bioavailability and excellent brain penetration affording high levels of receptor occupancy and in vivo efficacy in auditory sensory gating and novel object recognition. The structural diversity of this compound and its preclinical in vitro and in vivo package support the hypothesis that α7 nAChR agonists may have potential as a pharmacotherapy for the treatment of cognitive deficits in schizophrenia." @default.
- W2022094603 created "2016-06-24" @default.
- W2022094603 creator A5007170367 @default.
- W2022094603 creator A5009412258 @default.
- W2022094603 creator A5010313758 @default.
- W2022094603 creator A5014994494 @default.
- W2022094603 creator A5020911658 @default.
- W2022094603 creator A5021725957 @default.
- W2022094603 creator A5024240272 @default.
- W2022094603 creator A5024777634 @default.
- W2022094603 creator A5026400908 @default.
- W2022094603 creator A5026560462 @default.
- W2022094603 creator A5027257819 @default.
- W2022094603 creator A5031431090 @default.
- W2022094603 creator A5035698468 @default.
- W2022094603 creator A5036093371 @default.
- W2022094603 creator A5037158935 @default.
- W2022094603 creator A5037473441 @default.
- W2022094603 creator A5042373014 @default.
- W2022094603 creator A5043332165 @default.
- W2022094603 creator A5044903576 @default.
- W2022094603 creator A5045329484 @default.
- W2022094603 creator A5071798264 @default.
- W2022094603 creator A5078998491 @default.
- W2022094603 creator A5080415405 @default.
- W2022094603 creator A5089376121 @default.
- W2022094603 creator A5090364105 @default.
- W2022094603 creator A5032077424 @default.
- W2022094603 date "2009-12-31" @default.
- W2022094603 modified "2023-10-03" @default.
- W2022094603 title "Discovery of 4-(5-Methyloxazolo[4,5-<i>b</i>]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a Novel α7 Nicotinic Acetylcholine Receptor Agonist for the Treatment of Cognitive Disorders in Schizophrenia: Synthesis, SAR Development, and in Vivo Efficacy in Cognition Models" @default.
- W2022094603 cites W1565289973 @default.
- W2022094603 cites W1954604268 @default.
- W2022094603 cites W1963673462 @default.
- W2022094603 cites W1967286229 @default.
- W2022094603 cites W1968593789 @default.
- W2022094603 cites W1971576322 @default.
- W2022094603 cites W1974306203 @default.
- W2022094603 cites W1974560730 @default.
- W2022094603 cites W1993112595 @default.
- W2022094603 cites W1993337719 @default.
- W2022094603 cites W1999114713 @default.
- W2022094603 cites W2000811322 @default.
- W2022094603 cites W2000913567 @default.
- W2022094603 cites W2003556635 @default.
- W2022094603 cites W2013480397 @default.
- W2022094603 cites W2015066232 @default.
- W2022094603 cites W2016783506 @default.
- W2022094603 cites W2019363012 @default.
- W2022094603 cites W2024744942 @default.
- W2022094603 cites W2026139450 @default.
- W2022094603 cites W2026265479 @default.
- W2022094603 cites W2032461048 @default.
- W2022094603 cites W2047321326 @default.
- W2022094603 cites W2051664010 @default.
- W2022094603 cites W2055595940 @default.
- W2022094603 cites W2064730371 @default.
- W2022094603 cites W2065278977 @default.
- W2022094603 cites W2070290419 @default.
- W2022094603 cites W2071941035 @default.
- W2022094603 cites W2072441360 @default.
- W2022094603 cites W2072442323 @default.
- W2022094603 cites W2076972826 @default.
- W2022094603 cites W2083269966 @default.
- W2022094603 cites W2083540742 @default.
- W2022094603 cites W2086466562 @default.
- W2022094603 cites W2088421317 @default.
- W2022094603 cites W2091698874 @default.
- W2022094603 cites W2104594197 @default.
- W2022094603 cites W2107763854 @default.
- W2022094603 cites W2108982217 @default.
- W2022094603 cites W2111504432 @default.
- W2022094603 cites W2113758182 @default.
- W2022094603 cites W2120349084 @default.
- W2022094603 cites W2120431726 @default.
- W2022094603 cites W2124533302 @default.
- W2022094603 cites W2125605704 @default.
- W2022094603 cites W2129488948 @default.
- W2022094603 cites W2132980997 @default.
- W2022094603 cites W2144671685 @default.
- W2022094603 cites W2145593805 @default.
- W2022094603 cites W2160095486 @default.
- W2022094603 cites W2161004893 @default.
- W2022094603 cites W2162845180 @default.
- W2022094603 cites W2163175442 @default.
- W2022094603 cites W2168425360 @default.
- W2022094603 cites W2170194206 @default.
- W2022094603 cites W2326121756 @default.
- W2022094603 cites W237233758 @default.
- W2022094603 cites W2951178485 @default.
- W2022094603 cites W2952349576 @default.
- W2022094603 cites W4247556132 @default.
- W2022094603 cites W641042158 @default.
- W2022094603 doi "https://doi.org/10.1021/jm9015075" @default.
- W2022094603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20043678" @default.
- W2022094603 hasPublicationYear "2009" @default.
- W2022094603 type Work @default.
- W2022094603 sameAs 2022094603 @default.